SCHEMBL24087956

SCHEMBL24087956

N#Cc1c(-c2cccs2)cc(=O)[nH]c1SCc1cc(F)c(O)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ PIM1 P11309 2/20 0.46
▸ ACMSD Q8TDX5 6/20 0.41
▸ RXFP1 Q9HBX9 5/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ PRNP P04156 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ SAE1 Q9UBE0 1/20 0.41
▸ UBA2 Q9UBT2 1/20 0.41
▸ MAPT P10636 4/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847345 0.90 KDM4E (0.46) KDM4EPIM1ACMSDRXFP1MEN1
SCHEMBL24087884 0.85 ACMSD (0.44) KDM4EPIM1ACMSDRXFP1MEN1
SCHEMBL24087879 0.83 ALDH1A1 (0.35) KDM4EACMSDRXFP1MEN1KMT2A
SCHEMBL26847199 0.80 ACMSD (0.48) KDM4EPIM1ACMSDRXFP1MEN1
SCHEMBL23850235 0.80 ACMSD (0.64) KDM4EPIM1ACMSDRXFP1MEN1
SCHEMBL20339975 0.80 ACMSD (0.64) KDM4EPIM1ACMSDKMT2AALDH1A1
SCHEMBL23853857 0.77 PRNP (0.69) KDM4EACMSDRXFP1MEN1KMT2A
SCHEMBL24087880 0.77 ALDH1A1 (0.42) KDM4EACMSDKMT2APKMMAPT
SCHEMBL20351090 0.77 ACMSD (0.49) KDM4EPIM1ACMSDRXFP1MEN1
SCHEMBL20350994 0.76 ACMSD (0.49) KDM4EPIM1ACMSDRXFP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S R L (IT) 2021-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885PIM1 4131/4885ACMSD 1/4885
US-20210379069-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885PIM1 4131/4885ACMSD 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback